Immune checkpoint inhibitors: recent progress and potential biomarkers.

Darvin P, Toor SM, Sasidharan Nair V, Elkord E

DOI: 10.1038/s12276-018-0191-1
Published: 2018 Dec 13
Container: Experimental & molecular medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s12276-018-0191-1,
  title = {Immune checkpoint inhibitors: recent progress and potential biomarkers.},
  author = {Darvin P and Toor SM and Sasidharan Nair V and Elkord E},
  year = {2018},
  journal = {Experimental \& molecular medicine},
  doi = {10.1038/s12276-018-0191-1},
  url = {https://doi.org/10.1038/s12276-018-0191-1}
}

RIS

TY  - JOUR
TI  - Immune checkpoint inhibitors: recent progress and potential biomarkers.
AU  - Darvin P
AU  - Toor SM
AU  - Sasidharan Nair V
AU  - Elkord E
PY  - 2018
JO  - Experimental & molecular medicine
DO  - 10.1038/s12276-018-0191-1
UR  - https://doi.org/10.1038/s12276-018-0191-1
ER  -

APA

P, D., SM, T., V, S. N., & E, E. (2018). Immune checkpoint inhibitors: recent progress and potential biomarkers.. Experimental & molecular medicine. https://doi.org/10.1038/s12276-018-0191-1

Source records

pubmed · retrieved 2026-09-26T00:19:02.777Z